Zehra Demirci on Diagnostic Challenges and Clinical Implications in Polycythemia Vera
Zehra Demirci, Medical Student at Cerrahpasa Faculty of Medicine, shared on LinkedIn:
”I am thrilled to share a significant milestone in my academic journey: the publication of my first-ever article as a lead author in Expert Review of Hematology.
In this editorial, we provide a comprehensive overview of “Masked Polycythemia Vera,” defining it as a distinct presentation where patients exhibit the molecular and histologic features of PV despite having normal or borderline hemoglobin levels.
We discuss how various confounding factors—ranging from iron deficiency and occult bleeding to hemoglobinopathies—can obscure the diagnosis by suppressing red cell parameters.
Furthermore, we address the critical clinical implications, emphasizing that these “masked” patients often face a higher risk of thrombotic events and disease progression due to delayed recognition and undertreatment.
Finally, we emphasize the importance of evolving towards personalized treatment approaches and a comprehensive diagnostic model combining molecular and morphological insights to ensure early detection and improved prognosis.
It was a privilege to share the first authorship of this work with my dear colleague Zeynep Aslı Durak.
I would like to express my sincere gratitude to her for this great partnership and to our mentor Ahmet Emre Eşkazan for his invaluable guidance throughout the process.”
Read the full article here.
Article: Masked polycythemia vera: diagnostic challenges and clinical implications
Authors: Zeynep Aslı Durak, Zehra Demirci, Ahmet Emre Eşkazan

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines